FDA requests class label change for atypical antipsychotics

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1406, 2003-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FDA requests Boxed Warnings on conventional antipsychotics

By  

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Off-label use of atypical antipsychotics in personality disorders

By Rosenbluth Michael   Sinyor Mark  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 11, 2012-08 ,pp. : 1575-1585

Informa Healthcare

Access to resources Recommend Favorite

Off-Label Use of Atypical Antipsychotics: Cause for Concern?

By McKean Andrew  

CNS Drugs, Vol. 26, Iss. 5, 2012-05 ,pp. : 383-390

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics "widely used off-label", despite warnings

By  

Reactions Weekly, Vol. 1, Iss. 1302, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics "widely used off-label", despite warnings

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 604, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite